Experimental gene transfer to the corneal endothelium

Experimental Eye Research

Volumn 95, Issue 1, 2012, Pages 54-59

  Kampik, D ^a   Ali, R R ^a   Larkin, D F P ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

Adeno associated virus; Adenovirus; Corneal endothelium; Corneal transplantation; Gene therapy; Gene transfer; Lentivirus

Indexed keywords

ADENOVIRUS VECTOR; COMPLEMENTARY DNA; INDOLEAMINE 2,3 DIOXYGENASE; NERVE GROWTH FACTOR; NONVIRUS VECTOR; UNCLASSIFIED DRUG; VIRUS VECTOR;

ALLOTRANSPLANTATION; APOPTOSIS; ARTICLE; CELL DENSITY; CORNEA DISEASE; CORNEA ENDOTHELIUM; CORNEA THICKNESS; CORNEA TRANSPLANTATION; DNA MODIFICATION; DRUG EFFICACY; DRUG SAFETY; ELECTROPORATION; ENDOTHELIUM CELL; FEASIBILITY STUDY; FLUORESCENCE; FLUORESCENT ANTIBODY TECHNIQUE; GENE DELIVERY SYSTEM; GENE INDUCTION; GENE REPLICATION; GENE TARGETING; GENE TRANSFER; GENETIC TRANSDUCTION; GRAFT REJECTION; HISTOCHEMISTRY; HUMAN; IMMUNOGENETICS; IMMUNOMODULATION; IMMUNOREGULATION; MARKER GENE; NONHUMAN; PRIORITY JOURNAL; TRANSGENE;

ANIMALS; CORNEA; CORNEAL DISEASES; CORNEAL TRANSPLANTATION; ENDOTHELIAL CELLS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GRAFT REJECTION; HUMANS;

EID: 84856532072     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2011.07.001     Document Type: Article

References (75)

1. Aiuti A., Cattaneo F., Galimberti S., Benninghoff U., Cassani B., Callegaro L., Scaramuzza S., Andolfi G., Mirolo M., Brigida I., Tabucchi A., Carlucci F., Eibl M., Aker M., Slavin S., Al-Mousa H., Al G.A., Ferster A., Duppenthaler A., Notarangelo L., Wintergerst U., Buckley R.H., Bregni M., Marktel S., Valsecchi M.G., Rossi P., Ciceri F., Miniero R., Bordignon C., Roncarolo M.G. Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N.Engl. J. Med. 2009, 360:447-458.
2. Alba R., Bosch A., Chillon M. Gutless adenovirus: last-generation adenovirus for gene therapy. Gene Ther. 2005, 12(Suppl 1):S18-S27.
3. Albon J., Tullo A.B., Aktar S., Boulton M.E. Apoptosis in the endothelium of human corneas for transplantation. Invest. Ophthalmol. Vis. Sci. 2000, 41:2887-2893.
4. Auricchio A. Pseudotyped AAV vectors for constitutive and regulated gene expression in the eye. Vis. Res. 2003, 43:913-918.
5. Bainbridge J.W., Smith A.J., Barker S.S., Robbie S., Henderson R., Balaggan K., Viswanathan A., Holder G.E., Stockman A., Tyler N., Petersen-Jones S., Bhattacharya S.S., Thrasher A.J., Fitzke F.W., Carter B.J., Rubin G.S., Moore A.T., Ali R.R. Effect of gene therapy on visual function in Leber's congenital amaurosis. N.Engl. J. Med. 2008, 358:2231-2239.
6. Barcia R.N., Dana M.R., Kazlauskas A. Corneal graft rejection is accompanied by apoptosis of the endothelium and is prevented by gene therapy with bcl-xL. Am. J. Transplant 2007, 7:2082-2089.
7. Bennett J. Immune response following intraocular delivery of recombinant viral vectors. Gene Ther. 2003, 10:977-982.
8. Bertelmann E., Ritter T., Vogt K., Reszka R., Hartmann C., Pleyer U. Efficiency of cytokine gene transfer in corneal endothelial cells and organ-cultured corneas mediated by liposomal vehicles and recombinant adenovirus. Ophthalmic Res. 2003, 35:117-124.
9. Beutelspacher S.C., Ardjomand N., Tan P.H., Patton G.S., Larkin D.F., George A.J., McClure M.O. Comparison of HIV-1 and EIAV-based lentiviral vectors in corneal transduction. Exp. Eye Res. 2005, 80:787-794.
10. Beutelspacher S.C., Pillai R., Watson M.P., Tan P.H., Tsang J., McClure M.O., George A.J., Larkin D.F. Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression. Eur. J. Immunol. 2006, 36:690-700.
11. Biswas S., Munier F.L., Yardley J., Hart-Holden N., Perveen R., Cousin P., Sutphin J.E., Noble B., Batterbury M., Kielty C., Hackett A., Bonshek R., Ridgway A., McLeod D., Sheffield V.C., Stone E.M., Schorderet D.F., Black G.C. Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy. Hum. Mol. Genet. 2001, 10:2415-2423.
12. Blaese R.M., Culver K.W., Miller A.D., Carter C.S., Fleisher T., Clerici M., Shearer G., Chang L., Chiang Y., Tolstoshev P., Greenblatt J.J., Rosenberg S.A., Klein H., Berger M., Mullen C.A., Ramsey W.J., Muul L., Morgan R.A., Anderson W.F. Tlymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science 1995, 270:475-480.
13. Buch P.K., Bainbridge J.W., Ali R.R. AAV-mediated gene therapy for retinal disorders: from mouse to man. Gene Ther. 2008, 15:849-857.
14. Budenz D.L., Bennett J., Alonso L., Maguire A. In vivo gene transfer into murine corneal endothelial and trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 1995, 36:2211-2215.
15. Cartier N., Hacein-Bey-Abina S., Bartholomae C.C., Veres G., Schmidt M., Kutschera I., Vidaud M., Abel U., Dal-Cortivo L., Caccavelli L., Mahlaoui N., Kiermer V., Mittelstaedt D., Bellesme C., Lahlou N., Lefrere F., Blanche S., Audit M., Payen E., Leboulch P., l'Homme B., Bougneres P., Von K.C., Fischer A., Cavazzana-Calvo M., Aubourg P. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 2009, 326:818-823.
16. Cavazzana-Calvo M., Hacein-Bey S., de Saint B.G., Gross F., Yvon E., Nusbaum P., Selz F., Hue C., Certain S., Casanova J.L., Bousso P., Deist F.L., Fischer A. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000, 288:669-672.
17. Cavazzana-Calvo M., Payen E., Negre O., Wang G., Hehir K., Fusil F., Down J., Denaro M., Brady T., Westerman K., Cavallesco R., Gillet-Legrand B., Caccavelli L., Sgarra R., Maouche-Chretien L., Bernaudin F., Girot R., Dorazio R., Mulder G.J., Polack A., Bank A., Soulier J., Larghero J., Kabbara N., Dalle B., Gourmel B., Socie G., Chretien S., Cartier N., Aubourg P., Fischer A., Cornetta K., Galacteros F., Beuzard Y., Gluckman E., Bushman F., Hacein-Bey-Abina S., Leboulch P. Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia. Nature 2010, 467:318-322.
18. Challa P., Luna C., Liton P.B., Chamblin B., Wakefield J., Ramabhadran R., Epstein D.L., Gonzalez P. Lentiviral mediated gene delivery to the anterior chamber of rodent eyes. Mol. Vis. 2005, 11:425-430.
19. Collins L., Fabre J.W. Asynthetic peptide vector system for optimal gene delivery to corneal endothelium. J. Gene Med. 2004, 6:185-194.
20. Comer R.M., King W.J., Ardjomand N., Theoharis S., George A.J., Larkin D.F. Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival. Invest. Ophthalmol. Vis. Sci. 2002, 43:1095-1103.
21. DeGregori J., Leone G., Miron A., Jakoi L., Nevins J.R. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. U.S.A 1997, 94:7245-7250.
22. DeGregori J., Leone G., Ohtani K., Miron A., Nevins J.R. E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity. Genes Dev. 1995, 9:2873-2887.
23. Dull T., Zufferey R., Kelly M., Mandel R.J., Nguyen M., Trono D., Naldini L. Athird-generation lentivirus vector with a conditional packaging system. J.Virol. 1998, 72:8463-8471.
24. Engler C., Kelliher C., Wahlin K.J., Speck C.L., Jun A.S. Comparison of non-viral methods to genetically modify and enrich populations of primary human corneal endothelial cells. Mol. Vis. 2009, 15:629-637.
25. Fehervari Z., Rayner S.A., Oral H.B., George A.J., Larkin D.F. Gene transfer to exvivo stored corneas. Cornea 1997, 16:459-464.
26. Follenzi A., Santambrogio L., Annoni A. Immune responses to lentiviral vectors. Curr. Gene Ther. 2007, 7:306-315.
27. Fuchsluger T.A., Jurkunas U., Kazlauskas A., Dana R. Anti-apoptotic gene therapy prolongs survival of corneal endothelial cells during storage. Gene Ther. 2011.
28. Fuchsluger T.A., Jurkunas U., Kazlauskas A., Dana R. Corneal endothelial cells are protected from apoptosis by gene therapy. Hum. Gene Ther. 2011, 22:549-558.
29. Gaspar H.B., Bjorkegren E., Parsley K., Gilmour K.C., King D., Sinclair J., Zhang F., Giannakopoulos A., Adams S., Fairbanks L.D., Gaspar J., Henderson L., Xu-Bayford J.H., Davies E.G., Veys P.A., Kinnon C., Thrasher A.J. Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning. Mol. Ther. 2006, 14:505-513.
30. Gong N., Pleyer U., Vogt K., Anegon I., Flugel A., Volk H.D., Ritter T. Local overexpression of nerve growth factor in rat corneal transplants improves allograft survival. Invest. Ophthalmol. Vis. Sci. 2007, 48:1043-1052.
31. Hartman Z.C., Appledorn D.M., Amalfitano A. Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications. Virus Res. 2008, 132:1-14.
32. Hauswirth W.W., Aleman T.S., Kaushal S., Cideciyan A.V., Schwartz S.B., Wang L., Conlon T.J., Boye S.L., Flotte T.R., Byrne B.J., Jacobson S.G. Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum. Gene Ther. 2008, 19:979-990.
33. Hoffman L.M., Maguire A.M., Bennett J. Cell-mediated immune response and stability of intraocular transgene expression after adenovirus-mediated delivery. Invest. Ophthalmol. Vis. Sci. 1997, 38:2224-2233.
34. Hudde T., Comer R.M., Kinsella M.T., Buttery L., Luthert P.J., Polak J.M., George A.J., Larkin D.F. Modulation of hydrogen peroxide induced injury to corneal endothelium by virus mediated catalase gene transfer. Br. J. Ophthalmol. 2002, 86:1058-1062.
35. Hudde T., Rayner S.A., Comer R.M., Weber M., Isaacs J.D., Waldmann H., Larkin D.F., George A.J. Activated polyamidoamine dendrimers, a non-viral vector forgene transfer to the corneal endothelium. Gene Ther. 1999, 6:939-943.
36. Hudde T., Rayner S.A., De Alwis M., Thrasher A.J., Smith J., Coffin R.S., George A.J., Larkin D.F. Adeno-associated and herpes simplex viruses as vectors for gene transfer to the corneal endothelium. Cornea 2000, 19:369-373.
37. Jessup C.F., Brereton H.M., Coster D.J., Williams K.A. In vitro adenovirus mediated gene transfer to the human cornea. Br. J. Ophthalmol. 2005, 89:658-661.
38. Jessup C.F., Brereton H.M., Sykes P.J., Thiel M.A., Coster D.J., Williams K.A. Local gene transfer to modulate rat corneal allograft rejection. Invest. Ophthalmol. Vis. Sci. 2005, 46:1675-1681.
39. Joyce N.C. Proliferative capacity of the corneal endothelium. Prog.Retin.Eye Res. 2003, 22:359-389.
40. Joyce N.C. Cell cycle status in human corneal endothelium. Exp. Eye Res. 2005, 81:629-638.
41. Joyce N.C., Harris D.L. Decreasing expression of the G1-phase inhibitors, p21Cip1 and p16INK4a, promotes division of corneal endothelial cells from older donors. Mol. Vis. 2010, 16:897-906.
42. Joyce N.C., Harris D.L., Mc Alister J.C., Ali R.R., Larkin D.F. Effect of overexpressing the transcription factor E2F2 on cell cycle progression in rabbit corneal endothelial cells. Invest. Ophthalmol. Vis. Sci. 2004, 45:1340-1348.
43. Joyce N.C., Navon S.E., Roy S., Zieske J.D. Expression of cell cycle-associated proteins in human and rabbit corneal endothelium in situ. Invest. Ophthalmol. Vis. Sci. 1996, 37:1566-1575.
44. Jun A.S., Larkin D.F. Prospects for gene therapy in corneal disease. Eye 2003, 17:906-911.
45. Klebe S., Coster D.J., Sykes P.J., Swinburne S., Hallsworth P., Scheerlinck J.P., Krishnan R., Williams K.A. Prolongation of sheep corneal allograft survival by transfer of the gene encoding ovine IL-12-p40 but not IL-4 to donor corneal endothelium. J.Immunol. 2005, 175:2219-2226.
46. Klebe S., Sykes P.J., Coster D.J., Bloom D.C., Williams K.A. Gene transfer to ovine corneal endothelium. Clin. Experiment. Ophthalmol 2001, 29:316-322.
47. Klebe S., Sykes P.J., Coster D.J., Krishnan R., Williams K.A. Prolongation of sheep corneal allograft survival by exvivo transfer of the gene encoding interleukin-10. Transplantation 2001, 71:1214-1220.
48. Komuro A., Hodge D.O., Gores G.J., Bourne W.M. Cell death during corneal storage at 4 degrees C. Invest. Ophthalmol. Vis. Sci. 1999, 40:2827-2832.
49. Lai C.M., Brankov M., Zaknich T., Lai Y.K., Shen W.Y., Constable I.J., Kovesdi I., Rakoczy P.E. Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization. Hum. Gene Ther. 2001, 12:1299-1310.
50. Lai Y.K., Shen W.Y., Brankov M., Lai C.M., Constable I.J., Rakoczy P.E. Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy. Gene Ther. 2002, 9:804-813.
51. Larkin D.F., Oral H.B., Ring C.J., Lemoine N.R., George A.J. Adenovirus-mediated gene delivery to the corneal endothelium. Transplantation 1996, 61:363-370.
52. Lebherz C., Maguire A., Tang W., Bennett J., Wilson J.M. Novel AAV serotypes for improved ocular gene transfer. J. Gene Med. 2008, 10:375-382.
53. Liu C., Cheng Q., Nguyen T., Bonanno J.A. Knockdown of NBCe1 invivo compromises the corneal endothelial pump. Invest. Ophthalmol. Vis. Sci. 2010, 51:5190-5197.
54. Liu J., Saghizadeh M., Tuli S.S., Kramerov A.A., Lewin A.S., Bloom D.C., Hauswirth W.W., Castro M.G., Schultz G.S., Ljubimov A.V. Different tropism of adenoviruses and adeno-associated viruses to corneal cells: implications for corneal gene therapy. Mol. Vis. 2008, 14:2087-2096.
55. Maguire A.M., Simonelli F., Pierce E.A., Pugh E.N., Mingozzi F., Bennicelli J., Banfi S., Marshall K.A., Testa F., Surace E.M., Rossi S., Lyubarsky A., Arruda V.R., Konkle B., Stone E., Sun J., Jacobs J., Dell'Osso L., Hertle R., Ma J.X., Redmond T.M., Zhu X., Hauck B., Zelenaia O., Shindler K.S., Maguire M.G., Wright J.F., Volpe N.J., McDonnell J.W., Auricchio A., High K.A., Bennett J. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N.Engl. J. Med. 2008, 358:2240-2248.
56. McAlister J.C., Joyce N.C., Harris D.L., Ali R.R., Larkin D.F. Induction of replication in human corneal endothelial cells by E2F2 transcription factor cDNA transfer. Invest. Ophthalmol. Vis. Sci. 2005, 46:3597-3603.
57. Oshima Y., Sakamoto T., Yamanaka I., Nishi T., Ishibashi T., Inomata H. Targeted gene transfer to corneal endothelium invivo by electric pulse. Gene Ther. 1998, 5:1347-1354.
58. Parker D.G., Brereton H.M., Coster D.J., Williams K.A. The potential of viral vector-mediated gene transfer to prolong corneal allograft survival. Curr. Gene Ther. 2009, 9:33-44.
59. Parker D.G., Coster D.J., Brereton H.M., Hart P.H., Koldej R., Anson D.S., Williams K.A. Lentivirus-mediated gene transfer of interleukin 10 to the ovine and human cornea. Clin. Experiment. Ophthalmol. 2010, 38:405-413.
60. Parker D.G., Kaufmann C., Brereton H.M., Anson D.S., Francis-Staite L., Jessup C.F., Marshall K., Tan C., Koldej R., Coster D.J., Williams K.A. Lentivirus-mediated gene transfer to the rat, ovine and human cornea. Gene Ther. 2007, 14:760-767.
61. Pleyer U., Bertelmann E., Rieck P., Hartmann C., Volk H.D., Ritter T. Survival of corneal allografts following adenovirus-mediated gene transfer of interleukin-4. Graefes Arch. Clin. Exp Ophthalmol. 2000, 238:531-536.
62. Pleyer U., Groth D., Hinz B., Keil O., Bertelmann E., Rieck P., Reszka R. Efficiency and toxicity of liposome-mediated gene transfer to corneal endothelial cells. Exp. Eye Res. 2001, 73:1-7.
63. Qian Y., Leong F.L., Kazlauskas A., Dana M.R. Ex vivo adenovirus-mediated gene transfer to corneal graft endothelial cells in mice. Invest. Ophthalmol. Vis. Sci. 2004, 45:2187-2193.
64. Rayner S.A., Larkin D.F., George A.J. TNF receptor secretion after exvivo adenoviral gene transfer to cornea and effect on invivo graft survival. Invest. Ophthalmol. Vis. Sci. 2001, 42:1568-1573.
65. Ritter T., Yang J., Dannowski H., Vogt K., Volk H.D., Pleyer U. Effects of interleukin-12p40 gene transfer on rat corneal allograft survival. Transpl. Immunol. 2007, 18:101-107.
66. Somia N., Verma I.M. Gene therapy: trials and tribulations. Nat. Rev. Genet. 2000, 1:91-99.
67. Suh L.H., Zhang C., Chuck R.S., Stark W.J., Naylor S., Binley K., Chakravarti S., Jun A.S. Cryopreservation and lentiviral-mediated genetic modification of human primary cultured corneal endothelial cells. Invest. Ophthalmol. Vis. Sci. 2007, 48:3056-3061.
68. Tan P.H., Manunta M., Ardjomand N., Xue S.A., Larkin D.F., Haskard D.O., Taylor K.M., George A.J. Antibody targeted gene transfer to endothelium. J. Gene Med. 2003, 5:311-323.
69. Thiel M.A., Saydam C., Pavlovic J., Hemmi S. Effect of exvivo gene transfer with an adenoviral vector on human eye bank corneas. Ophthalmic Res. 2005, 37:67-71.
70. Toma N.M., Ebenezer N.D., Inglehearn C.F., Plant C., Ficker L.A., Bhattacharya S.S. Linkage of congenital hereditary endothelial dystrophy to chromosome 20. Hum. Mol. Genet. 1995, 4:2395-2398.
71. Uchida E., Mizuguchi H., Ishii-Watabe A., Hayakawa T. Comparison of the efficiency and safety of non-viral vector-mediated gene transfer into a wide range of human cells. Biol. Pharm. Bull. 2002, 25:891-897.
72. Vithana E.N., Morgan P., Sundaresan P., Ebenezer N.D., Tan D.T., Mohamed M.D., Anand S., Khine K.O., Venkataraman D., Yong V.H., Salto-Tellez M., Venkatraman A., Guo K., Hemadevi B., Srinivasan M., Prajna V., Khine M., Casey J.R., Inglehearn C.F., Aung T. Mutations in sodium-borate cotransporter SLC4A11 cause recessive congenital hereditary endothelial dystrophy (CHED2). Nat. Genet. 2006, 38:755-757.
73. Wang X., Appukuttan B., Ott S., Patel R., Irvine J., Song J., Park J.H., Smith R., Stout J.T. Efficient and sustained transgene expression in human corneal cells mediated by a lentiviral vector. Gene Ther. 2000, 7:196-200.
74. Yanez-Munoz R.J., Balaggan K.S., MacNeil A., Howe S.J., Schmidt M., Smith A.J., Buch P., MacLaren R.E., Anderson P.N., Barker S.E., Duran Y., Bartholomae C., von Kalle C., Heckenlively J.R., Kinnon C., Ali R.R., Thrasher A.J. Effective gene therapy with nonintegrating lentiviral vectors. Nat. Med. 2006, 12:348-353.
75. Zufferey R., Nagy D., Mandel R.J., Naldini L., Trono D. Multiply attenuated lentiviral vector achieves efficient gene delivery invivo. Nat. Biotechnol. 1997, 15:871-875.